Business Wire

CGTN: What Are Generations of Chinese Communists Striving For?

27.2.2021 18:36:00 EET | Business Wire | Press release

Share

The Communist Party of China (CPC), the ruling party of the world's most populous nation and the second largest economy, is turning 100 this year. What has been motivating the CPC to fight against one challenge after another over the past century?

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210227005021/en/

"The original aspiration and the mission of Chinese Communists is to seek happiness for the Chinese people and rejuvenation for the Chinese nation," General Secretary Xi Jinping of the CPC Central Committee said in his report to the 19th CPC National Congress in October 2017.

"This founding aspiration, this mission, is what inspires the Chinese Communists to advance," Xi said.

Self-discipline, selflessness

In March 2018, Xi, also the Chinese president, further explained the cause pursued by the CPC with a quote from an ancient poem: "A virtuous person is as sharp-sighted as a clear mirror hanging high, a selfless person is just like a lit candle giving all of its light to others."

He made the quotation at a symposium to commemorate the 120th birthday of late Premier Zhou Enlai (1898-1976), who joined the CPC in 1921, the year when the Party was founded.

"The lofty character of comrade Zhou Enlai, who selflessly pursued a just cause for the common good throughout his life, vividly reflects the traditional virtue of the Chinese nation and good moral qualities of the Chinese Communists, and will forever earn the respect of future generations," said Xi.

The comments "not only aimed to remember the noble character of Zhou who was self-disciplined, upright, honest and selfless, but also to encourage today's Communists to stay true to their original aspirations of the Party and shoulder their responsibilities," said Meng Man, a history professor at Minzu University of China.

New challenges, same aspiration

The number of the CPC members has exceeded 90 million, and China has become a much stronger nation than 100 years ago and the early decades of the People's Republic of China, but the aspiration of the Chinese Communists remains unchanged.

"To meet the people's desire for a happy life is our mission," Xi said when meeting the press after being elected as general secretary of the CPC Central Committee in November 2012.

Three years later, the communique of the fifth plenary session of the 18th CPC Central Committee underscored a people-centered development philosophy, stressing that China's development must be for the people and by the people, and its fruits shared among the people.

The notion was highlighted again in the CPC Central Committee's proposals for formulating the 14th Five-Year Plan (2021-2025) for National Economic and Social Development and the Long-Range Objectives Through the Year 2035, which called for efforts to promote common prosperity for everyone.

China, in recent years, has been striving to build a moderately prosperous society in all respects and pursuing more balanced development. The CPC members have played leading roles in a nationwide poverty alleviation campaign to make sure nobody is left behind.

Over the past eight years, more than three million public sector officials were sent from cities and towns to villages to fight against poverty on the front lines and over 1,800 people died during the fight, Xi said on Thursday after announcing the country's "complete victory" in eradicating absolute poverty.

Putting people's life and health first, China has taken strict measures to battle the COVID-19 pandemic and effectively contained the virus, thanks to people from all walks of life for their efforts and sacrifices, particularly the CPC members.

More than 39 million CPC members fought the virus at the front line, and more than 13 million volunteered their services. Nearly 400 CPC members have defended others' lives and safety at the cost of their own.

When many parts of the country grappled with severe floods last summer, the Organization Department of the CPC Central Committee issued a circular to call on primary-level CPC organizations and members to fully play their role in flood control and relief work, urging them to ensure the safety of people's lives and property.

As China embarks on a new journey to fully build a modern socialist country, today's Chinese Communists – putting the people's and the nation's interests above those of themselves – are gearing up to take on their responsibilities as the older generations did.

Original article: https://news.cgtn.com/news/2021-02-27/What-are-generations-of-Chinese-Communists-striving-for--YdM2IOWzO8/index.html

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Jiang Simin
jiang.simin@cgtn.com
+86 18826553286

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 21:00:00 EET | Press release

Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham, MSc, MD, FRCPC, dermatologist, SKiN Centre for Dermatology, Peterborough, Ontario, Canada, principal investigator for the Latitude PsO studies and presenting author. “These efficacy and safety results show it’s possible for a once-daily pill to deliver rapid, lasting skin clearance, highlighting the potential of zasoc

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 21:00:00 EET | Press release

Incyte (Nasdaq:INCY) today announced 54-week data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). The late-breaking oral presentation of these data is taking place at the 2026 American Academy of Dermatology (AAD) Annual Meeting, being held March 27-31, 2026, in Denver (Session: S034 – Late-Breaking Research: Session 2. Saturday, March 28, 2026, 1:00-4:00 p.m. MT). “The 54-week results from the STOP-HS program deliver compelling, long-term evidence supporting the potential of povorcitinib for patients with moderate to severe HS,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “Across both studies, povorcitinib demonstrated substantial and durable improvements over time in key measures of treatment success and meaningful clinical ben

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 17:00:00 EET | Press release

Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-breaking session at the 2026 American Academy of Dermatology (AAD) Annual Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260328320362/en/ Atopic dermatitis is the most common inflammatory skin disorder in children, yet treatment options in the moderate-to-severe pediatric setting are limited.5 The disease can have a significant impact on quality of life for both the patients and their loved ones, with persistent itch and recurrent skin lesions often disrupting sleep, school and relationships.5-8 “Atopic dermatitis can affect many aspects of children’s lives including schoolwork, emotional development

Angelalign Technology (6699.HK) Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 21:56:00 EET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 19:46:00 EET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye